MYCL and Merkel cell skin cancer: Through unbiased genome-scale screens for regulators of HLA-I, we identified MYCL, which acts as part of the ST-MYCL-EP400 complex in MCPyV+ MCC and is frequently amplified in MCPyV– MCC (15, 28, 43, 61).